bluebird bio, Inc. (BLUE): Price and Financial Metrics
bluebird bio, Inc. (BLUE)
Today's Latest Price: $98.04 USD
0.57 (0.58%)
Updated Jan 17 12:00am
Add BLUE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BLUE Stock Summary
- bluebird bio Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 8.99% of US listed stocks.
- BLUE's price/sales ratio is 96.17; that's higher than the P/S ratio of 97.74% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.23 for bluebird bio Inc; that's greater than it is for just 12.63% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to bluebird bio Inc are AKTS, TBPH, RARE, APTX, and CUE.
- BLUE's SEC filings can be seen here. And to visit bluebird bio Inc's official web site, go to www.bluebirdbio.com.
BLUE Daily Price Range
BLUE 52-Week Price Range
BLUE Stock Price Chart More Charts
BLUE Price/Volume Stats
| Current price | $98.04 | 52-week high | $163.43 |
| Prev. close | $97.47 | 52-week low | $71.42 |
| Day low | $96.89 | Volume | 1,753,800 |
| Day high | $99.36 | Avg. volume | 1,034,242 |
| 50-day MA | $84.27 | Dividend yield | N/A |
| 200-day MA | $109.72 | Market Cap | 5.42B |
bluebird bio, Inc. (BLUE) Company Bio
Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies. The company was founded in 1992 and is based in Cambridge, Massachusetts.
Top Stories View All
Best & Worst Performing Stock Industries for January 20, 2020
Best & Worst Performing Small Cap Stocks for January 20, 2020
Best & Worst Performing Mid Cap Stocks for January 20, 2020
Best & Worst Performing Large Cap Stocks for January 20, 2020
Best & Worst Performing Mega Cap Stocks for January 20, 2020
View All Top Stories
Loading social stream, please wait...